Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kevin M Kalinsky
SWOG Cancer Research Network
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1,569 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Bcca-Abbotsford Cancer Centre
Abbotsford British Columbia, British Columbia, Canada
- Bcca-Cancer Centre for the Southern Interior
Kelowna, British Columbia, Canada
- Bcca-Fraser Valley Cancer Centre
Surrey, British Columbia, Canada
- Bcca-Vancouver Cancer Centre
Vancouver, British Columbia, Canada
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- Atlantic Health Sciences Corporation-Saint John Regional Hospital
Saint John, New Brunswick, Canada
- Doctor H. Bliss Murphy Cancer Centre
St. John's, Newfoundland and Labrador, Canada
- Royal Victoria Regional Health Centre
Barrie, Ontario, Canada
- Health Sciences North
Greater Sudbury, Ontario, Canada
- Juravinski Cancer Centre at Hamilton Health Sciences
Hamilton, Ontario, Canada
- Waterloo Regional Health Network
Kitchener, Ontario, Canada
- Trillium Health Partners - Credit Valley Hospital
Mississauga, Ontario, Canada
- Thunder Bay Regional Health Science Centre
Thunder Bay, Ontario, Canada
- Michael Garron Hospital
Toronto, Ontario, Canada
- Mount Sinai Hospital
Toronto, Ontario, Canada
- Trillium Health Partners - Queensway Health Centre
Toronto, Ontario, Canada
- University Health Network-Princess Margaret Hospital
Toronto, Ontario, Canada
- Pei Cancer Treatment Centre-Queen Elizabeth Hospital
Charlottetown, Prince Edward Island, Canada
- Chum - Centre Hospitalier de L'Universite de Montreal
Montreal, Quebec, Canada
- Chum-Hotel Dieu de Montreal
Montreal, Quebec, Canada
- Ciusssemtl-Hopital Maisonneuve-Rosemont
Montreal, Quebec, Canada
- Jewish General Hospital
Montreal, Quebec, Canada
- Mcgill University Department of Oncology
Montreal, Quebec, Canada
- the Research Institute of the Mcgill University Health Centre (muhc)
Montreal, Quebec, Canada
- Chu de Quebec-Hopital Du Saint-Sacrement (hss)
Québec, Quebec, Canada
- Centre Hospitalier Universitaire de Sherbrooke-Fleurimont
Sherbrooke, Quebec, Canada
- Allan Blair Cancer Centre
Regina, Saskatchewan, Canada
- Saskatoon Cancer Centre
Saskatoon, Saskatchewan, Canada
- Instituto Nacional de Cancerologia
Bogotá, Colombia
- Institut de Cancerologie de L'Ouest- Angers
Angers, France
- Centre Hospitalier D'Auch
Auch, France
- Institut Sainte Catherine
Avignon, France
- Centre Hospitalier de la Cote Basque
Bayonne, France
- Centre D'Oncologie Et de Radiotherapie Pays Basque
Bayonne, France
- Centre Hospitalier de Beauvais
Beauvais, France
- Centre Hospitalier de Blois
Blois, France
- Clinique Tivoli Ducos
Bordeaux, France
- Institut Bergonie Cancer Center
Bordeaux, France
- Polyclinic Bordeaux Nord Aquitaine
Bordeaux, France
- Chu de Brest-Hopital Morvan
Brest, France
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2011
- Primary completion
- 1 Feb 2023
- Completion
- 8 Jan 2027
- Last update posted
- 2 Jul 2026
- Registered enrollment
- 5,018
- Registry id
- NCT01272037
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.